ArticlePharmacoEconomics2005

The case of tumour necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritis: a budget impact analysis.

Jan Sørensen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.